Merck & Co., Inc. (MRK) Investment Research Dashboard
About Merck & Co., Inc. (MRK) stock analysis
Get live MRK stock price $131.84, comprehensive Merck & Co., Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time MRK stock data and investment insights.
Loading chart data...
Merck & Co., Inc. (MRK) Overview
Merck & Co., Inc. (MRK) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, MRK trades at $131.84 with a market capitalization of 325.61B . Over the past 52 weeks, MRK has traded between $76.66 and $135.05 , with the current price positioned at approximately 94% of this range . The stock curren...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 325.61B
- Current price: $131.84
- 52-week range: $76.66 - $135.05
- P/E ratio: 24.10
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover cruc...
Company Information
- CEO
- Robert Davis
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 75000
Contact Information
- Website
- https://www.merck.com
- Address
- 126 East Lincoln Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 325.6 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 24.1)
✓ Lower volatility stock (Beta: 0.20) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Merck & Co., Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Merck & Co., Inc.
- ⚠Investors should consider how Merck & Co., Inc. fits within their overall portfolio allocation
Market Cap
325.61B
P/E Ratio (TTM)
24.10
Beta
0.20
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare MRK with peer companies:
- Price
- $107.32+2.71% (1D)
- Market cap
- 186.93B
- Price
- $393.10+4.48% (1D)
- Market cap
- 212.16B
- Price
- $172.48+1.67% (1D)
- Market cap
- 133.67B
- Price
- $134.32+2.91% (1D)
- Market cap
- 166.77B
- Price
- $53.71+3.33% (1D)
- Market cap
- 108.36B
- Price
- $50.96+2.60% (1D)
- Market cap
- 226.46B
- Price
- $159.85+2.40% (1D)
- Market cap
- 303.83B
- Price
- $25.25+2.35% (1D)
- Market cap
- 143.91B
- Price
- $45.54+3.50% (1D)
- Market cap
- 110.48B
- Price
- $576.41+3.02% (1D)
- Market cap
- 214.21B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.8 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.4% | 29.2 | 46/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 35/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-28.